Ayurvedic management of Amavata with special reference to Rheumatoid Arthritis: A Case Study
Department of Kayachikitsa, M. A. M.’s Sumatibhai Shah Ayurved Mahavidyalaya, Malwadi, Hadapsar, Pune- 411028, India.
Case Study
World Journal of Advanced Research and Reviews, 2022, 16(03), 1078-1082
Publication history:
Received on 15 November 2022; revised on 28 December 2022; accepted on 30 December 2022
Abstract:
Amavata is one of the crippling diseases. It is the systemic disorder in which pathogenic constituents are mainly Aama and Vata. The symptoms of Amavata are identical to Rheumatoid arthritis and Rheumatic fever. According to Ayurveda, Amavata is the disease which is mentioned under the category of Vata- Kaphaja vyadhi. Research has proven that Ayurvedic treatment is effective in the management of Amavata.
Present case study was done on the female patient of Amavata, we found that Ayurvedic medicines improve Jatharagni and leads to the formation of other Dhatu as well as stop the formation Aam. In this study, patient is having many complaints such as B/L knee joint pain & joint stiffness, local warmness & swelling over both knee, anorexia, dryness of mouth, fever (on & off ) etc. Patient was given Ayurvedic medicines such as Sihnad Guggul, Amavatari Rasa, Erand sneha and Shunthi jal with local application of Vishagarbha tail and Waluka pottali Sweda. Patient was feeling much better than earlier and she felt that about 80% of her symptoms got decreased.
From the modern aspect, the non-steroidal anti-inflammatory drugs (NSAID`S) and disease modifying anti-rheumatic drugs (DMARD`S) are the main stay in this condition, however they have serious adverse effects and have limitations for long term therapy. Continuous use of allopathic drugs leads to symptoms like constipation, nausea, abdominal discomfort. So we stopped the allopathic medicine and started above mentioned Ayurvedic treatment and gradually alleviated above symptoms.
Keywords:
Ama; Rheumatism; Amrita; Tinospora cordifolia; Ghee; Sihnad Guggul
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0